Latest Earnings Analysis
-
Corsair (CRSR) Q3 2025: Gross Margin Climbs 400bps on Product Mix and Supply Chain Leverage
November 05, 2025 · CRSR
-
Cryoport (CYRX) Q3 2025: Cell & Gene Therapy Revenue Climbs 36% as Commercial Pipeline Expands
November 05, 2025 · CYRX
-
Finance of America (FOA) Q3 2025: Adjusted Net Income Doubles as Digital Origination Surges
November 05, 2025 · FOA
-
Day One Biopharmaceuticals (DAWN) Q3 2025: Ojemda Prescriptions Jump 18%, Deepening Second-Line Standardization
November 05, 2025 · DAWN
-
Grocery Outlet (GO) Q3 2025: Store Refresh Delivers Mid-Single-Digit Comp Lift in Pilots, Accelerating 2026 Growth Path
November 05, 2025 · GO
-
AudioEye (AEYE) Q3 2025: Enterprise Channel Grows 26% as EU Pipeline Lifts ARR Trajectory
November 05, 2025 · AEYE
-
Lucky Strike (LUCK) Q1 2026: Food Sales Jump 10%, Rebrand Drives F&B Upside
November 05, 2025 · LUCK
-
Astronics (ATRO) Q3 2025: Backlog Holds at $647M as Margin Expansion and Acquisitions Reshape Trajectory
November 05, 2025 · ATRO
-
Allegiant (ALGT) Q3 2025: MAX Fleet Hits 20% of ASMs, Driving Margin Expansion Into 2026
November 05, 2025 · ALGT
-
Cerebel (CBLL) Q3 2025: Active Accounts Jump by 31, Unlocking Deeper Hospital Penetration
November 05, 2025 · CBLL
-
CAVA (CAVA) Q3 2025: 17% Unit Growth Offsets Modest 1.9% Same-Store Sales Amid Consumer Pressure
November 05, 2025 · CAVA
-
Accel Entertainment (ACEL) Q3 2025: Developing Markets Drive 30%+ Revenue Growth, Bolstering Local Gaming Expansion
November 05, 2025 · ACEL
-
Teradata (TDC) Q3 2025: Free Cash Flow Jumps 28% as Hybrid AI Workloads Drive Strategic Shift
November 05, 2025 · TDC
-
Soleno Therapeutics (SLNO) Q3 2025: Revenue Doubles as VICAT-XR Adoption Hits 764 Patients
November 05, 2025 · SLNO
-
Tempus AI (TEM) Q3 2025: Data Licensing Bookings Top $150M, Powering Durable Margin Turn
November 05, 2025 · TEM
-
Skyworks (SWKS) Q4 2025: Mobile Revenue Jumps 21% on Mix, Sets Stage for Corvo Merger
November 05, 2025 · SWKS
-
Arteris (AIP) Q3 2025: RPO Jumps 34% as AI and Chiplet Wins Broaden Revenue Visibility
November 05, 2025 · AIP
-
Rapid7 (RPD) Q3 2025: MDR Now Over 50% of ARR, Shifting Growth Focus and Margin Model
November 05, 2025 · RPD
-
IPGP Q3 2025: Emerging Growth Products Reach 52% of Sales as Medical and Defense Drive Strategic Shift
November 05, 2025 · TPG
-
Lumentum (LITE) Q1 2026: Cloud and AI Revenue Surges to 60% of Business, Capacity Constraints Drive Margin Leverage
November 05, 2025 · LITE
-
Clean Energy Fuels (CLNE) Q3 2025: Upstream RNG Output Doubles as Dairy Projects Ramp
November 05, 2025 · CLNE
-
Astera Labs (ALAB) Q3 2025: PCIe Gen 6 Surges to 20% of Revenue, Signaling Next-Gen AI Infrastructure Shift
November 05, 2025 · ALAB
-
Agilon Health (AGL) Q3 2025: $30M Cost Cuts and 9% Rate Tailwind Set Stage for 2026 Margin Rebuild
November 05, 2025 · AGL
-
Rivian (RIVN) Q3 2025: R2 Unit Economics Targeted for 50% BOM Reduction, Paving Path to Profitability
November 05, 2025 · RIVN
-
AMD (AMD) Q3 2025: Data Center Revenue Jumps 22% as AI Partnerships Drive Multi-Year Upside
November 05, 2025 · AMD
-
InnovAge (INNV) Q1 2026: Contribution Margin Expands 320bps as PACE Model Drives Cost Control
November 05, 2025 · INNV
-
Ouster (OUST) Q3 2025: Sensor Shipments Up 85% as Software-Attached Model Drives Market Penetration
November 05, 2025 · OUST
-
CORT (CORT) Q3 2025: Hypercortisolism Tablets Surge 42.5% as Pipeline Expands Oncology Reach
November 05, 2025 · CORT
-
AVNW Q1 2026: Gross Margin Surges 1,140bps as Private Network Wins and 4RF Integration Expand Profitability
November 05, 2025 · AVNW
-
Tarsus (TARS) Q3 2025: 147% Growth Underscores Xdemvi’s Blockbuster Trajectory
November 05, 2025 · TARS
-
Longevron (LGVN) Q3 2025: R&D Spend Rises 52% as HLHS Pivotal Data Nears
November 05, 2025 · LGVN
-
Toast (TOST) Q3 2025: ARR Doubles to $2B as New Verticals Fuel Next-Stage Growth
November 05, 2025 · TOST
-
Zeta (ZETA) Q3 2025: Athena AI Launch Fuels 28% Organic Growth, Extends Platform Differentiation
November 05, 2025 · ZETA
-
Supernus (SUPN) Q3 2025: 78% Revenue Concentration in Four Growth Brands Signals Portfolio Shift
November 05, 2025 · SUPN
-
Opportune Financial (OPRT) Q3 2025: Secured Loan Portfolio Climbs 48% as Credit Tightens
November 05, 2025 · OPRT
-
Personalis (PSNL) Q3 2025: MRD Clinical Test Volume Up 364% as Coverage Decisions Near
November 05, 2025 · PSNL
-
NeuroPace (NPCE) Q3 2025: RNS Revenue Jumps 31% as Platform Shift Accelerates Margin Expansion
November 05, 2025 · NPCE
-
PTC Therapeutics (PTCT) Q3 2025: Suffiance Launch Adds $19.6M, Broad Uptake Signals Durable PKU Franchise
November 05, 2025 · PTCT
-
Nuveen Churchill Direct Lending (NCDL) Q3 2025: Senior Loans Hold 90% as Origination Mix Tightens
November 05, 2025 · NCDL
-
NGL (NGL) Q2 2026: Water Disposal Volumes Up 14% as Delaware Basin Commitments Lock In Multi-Year Growth
November 05, 2025 · NGL
-
Comscore (SCOR) Q3 2025: Cross-Platform Revenue Jumps 20% as Local TV Momentum Accelerates
November 05, 2025 · SCOR
-
Solid Power (SLDP) Q3 2025: Operating Expenses Drop $4.4M as BMW-Samsung SDI Pact Advances Tech Roadmap
November 05, 2025 · SLDP
-
Revolve (RVLV) Q3 2025: Gross Margin Jumps 347bps as Own Brands and AI Fuel Profit Trajectory
November 05, 2025 · RVLV
-
OmniAb (OABI) Q3 2025: Program Count Hits 399, OmniUltra Launch Expands Peptide Market Access
November 05, 2025 · OABI
-
Veracyte (VCYT) Q3 2025: Decipher Volumes Up 26% as Margin Surges 650bps, Fueling Pipeline Acceleration
November 05, 2025 · VCYT
-
Trex (TREX) Q3 2025: New Products Drive 25% of Sales Amid 250bp Margin Headwind for 2026
November 05, 2025 · TREX
-
Perdoceo Education (PRDO) Q3 2025: Enrollment Jumps 15% on St. Augustine Acquisition, Corporate Channel Momentum
November 05, 2025 · PRDO
-
Pinterest (PINS) Q3 2025: International Revenue Climbs 66%, Unlocking Global Monetization Runway
November 05, 2025 · PINS
-
NMI Holdings (NMIH) Q3 2025: Book Value Per Share Up 16% as Expense Ratio Hits Record Low
November 05, 2025 · NMIH
-
Match Group (MTCH) Q3 2025: Hinge Revenue Jumps 27% as Product-Led Turnaround Targets Gen Z
November 05, 2025 · MTCH